CVRx is a commercial-stage medical device company. Co.'s proprietary platform technology, Barostim, is designed to utilize the brain to address the imbalance of the Autonomic Nervous System, which causes heart failure (HF) and other cardiovascular diseases. Co.'s product, Barostim, is commercially available neuromodulation device indicated to improve symptoms for patients with HF with reduced Ejection Fraction. Barostim provides Baroreflex Activation Therapy by sending imperceptible and persistent electrical pulses to baroreceptors located in the wall of the carotid artery to signal the brain to modulate the cardiovascular function. We show 10 historical shares outstanding datapoints in our CVRX shares outstanding history coverage, used to compute CVRX market cap on those dates.
Understanding the changing numbers of shares outstanding, the changing
share price, and the resulting changing CVRX market cap history over the course of time is important for investors
interested in comparing CVRX's market cap history versus its peers.
Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies,
and then calculating their respective market caps. Comparing the share price of CVRX versus a peer is one thing; comparing
CVRX market cap versus a peer is a completely different story.
Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares),
the market cap for a company like CVRX can fluctuate over the course of history.
With this page we aim to empower investors researching CVRX by allowing them to research the CVRX market cap history. |
Free CVRX Email Alerts:
Video: The Importance of Market Cap
